Buscar
-
The CD40-CD40L axis: Current and future implications in clinical immunology [L'axe CD40-CD40L : implications actuelles et futures en immunologie clinique]
(Revue de Medecine Interne. vol. 42, n° 10, pp. 722-728, 2021)Article de revue -
Restoration of t-cell effector function, depletion of tregs, and direct killing of tumor cells: The multiple mechanisms of action of a-tigit antagonist antibodies
(Molecular Cancer Therapeutics. vol. 20, n° 1, pp. 121-131, 2021-01-05)Article de revue -
Impact of Covid-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemic
(Nephrologie et Therapeutique. vol. 17, n° 4, pp. 245-251, 2021-08)Article de revue -
Characterization of the novel HLA-DRB3*02:192 allele by sequencing-based typing
(HLA. vol. 102, n° 5, pp. 640-641, 2023-08)Article de revue -
Characterization of the novel HLA-DPA1*01:159 allele by sequencing-based typing
(HLA. vol. 102, n° 5, pp. 647-648, 2023)Article de revue -
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
(Digestive and Liver Disease. vol. 55, pp. 61-68, 2022-08-16)Article de revue -
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2231-2242, 2023-08-21)Article de revue -
Dosage des auto-anticorps : y a-t-il une place pour le doute ?
(Revue du Rhumatisme (Edition Francaise). vol. 90, n° 5, pp. 626-633, 2023)Article de revue -
Characterization of the novel HLA-B*51:384 allele by sequencing-based typing
(HLA. vol. 102, n° 4, pp. 529-531, 2023-08-01)Article de revue -
Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series
(Journal of the European Academy of Dermatology and Venereology. vol. 37, n° 11, pp. 2264-2266, 2023-08-10)Article de revue